CRCardiovascular Reviews3083-48802981-8109Bio-Byword Scientific Publishing Pty. Ltd.10.26689/cr.v4i1.14285ArticleCorrelation Analysis Between Inflammatory Markers and Stroke Prevalence: A Cross- Sectional Analysis from NHANES 2017–2023https://artdesignp.com/journal/CR/4/1/10.26689/cr.v4i1.14285LiuMei,ZhaoYan,WuJin2026412026-03-19Systemic chronic inflammation drives cerebrovascular disease, and composite hematological inflammatory indicators, including Neutrophil-to-Lymphocyte Ratio (NLR), Monocyte-to-Lymphocyte Ratio (MLR), Neutrophil + Monocyte-to-Lymphocyte Ratio (NMLR), Systemic Inflammatory Response Index (SIRI), and Systemic Immune-Inflammation Index (SII), have proven prognostic in acute stroke. However, their comparative value for predicting stroke risk in the general population remains unaddressed. We conducted a cross-sectional study using NHANES 2017–2023 data, including 15,253 adults (658 with self-reported stroke). Survey-weighted analyses compared baseline characteristics, while weighted univariate logistic regression assessed associations between inflammatory indices and stroke risk. Receiver operating characteristic (ROC) curves evaluated diagnostic performance, and a composite scoring system ranked the indicators. Subgroup analyses tested consistency across demographics and comorbidities. All five inflammatory markers were significantly higher in stroke patients (all P < 0.01). NLR, MLR, NMLR, and SIRI correlated positively with stroke risk (OR range: 1.04–1.06, all P < 0.05), but SII did not. SIRI had the largest area under the curve (AUC = 0.597) and the highest composite score (integrating AUC, OR, sensitivity, and specificity). Associations remained consistent across genders, age groups, and individuals with or without diabetes or hypertension. Composite inflammatory indicators, particularly SIRI, may serve as potential biomarkers for stroke risk assessment in the general population. Their moderate diagnostic performance, however, limits standalone use; they are best employed as auxiliary tools in comprehensive risk evaluation.

GBD 2016 Stroke Collaborators, 2019, Global, Regional, and National Burden of Stroke, 1990–2016: A Systematic Analysis for the Global Burden of Disease Study 2016. The Lancet Neurology, 18(5): 439–458.

Bhatt N, Malik A, Chaturvedi S, 2018, Stroke in Young Adults: Five New Things. Neurology: Clinical Practice, 8(6): 501–506.

Parikh N, Merkler A, Iadecola C, 2020, Inflammation, Autoimmunity, Infection, and Stroke: Epidemiology and Lessons from Therapeutic Intervention. Stroke, 51(3): 711–718.

Van Der Ende N, Lingsma H, Venema E, et al., 2023, Symptomatic Intracranial Hemorrhage After Endovascular Stroke Treatment: External Validation of Prediction Models. Stroke, 54(2): 476–487.

Chavarria A, Alcocer-Varela J, 2004, Is Damage in Central Nervous System due to Inflammation? Autoimmunity Reviews, 3(4): 251–260.

Chamorro A, Hallenbeck J, 2006, The Harms and Benefits of Inflammatory and Immune Responses in Vascular Disease. Stroke, 37(2): 291–293.

Wang Q, Tang X, Yenari M, 2007, The Inflammatory Response in Stroke. Journal of Neuroimmunology, 184(1-2): 53–68.

Iadecola C, Buckwalter M, Anrather J, 2020, Immune Responses to Stroke: Mechanisms, Modulation, and Therapeutic Potential. The Journal of Clinical Investigation, 130(6): 2777–2788.

Xue W, Xu X, Tan Y, et al., 2019, Evaluating and Validating the Predictive Ability of Preoperative Systemic Inflammatory/Immune Cells in Gastric Cancer Following R0 Resection. Oncology Letters, 18(5): 5205–5214.

Centers for Disease Control and Prevention, 2001, NHANES Laboratory/Medical Technologists Procedures Manual. Atlanta, GA.

Wu B, Liu F, Sun G, et al., 2023, Prognostic Role of Dynamic Neutrophil-to-Lymphocyte Ratio in Acute Ischemic Stroke After Reperfusion Therapy: A Meta-Analysis. Frontiers in Neurology, 2023(14): 1118563.

Gök M, Kurtul A, 2021, A Novel Marker for Predicting Severity of Acute Ischemic Stroke: Systemic Immune-Inflammation Index. Neurological Research, 43(3): 181–187.

Lattanzi S, Brigo F, Trinka E, et al., 2019, Neutrophil-to-Lymphocyte Ratio in Acute Cerebral Hemorrhage: A Systematic Review. Translational Stroke Research, 10(2): 137–145.

Nam K, Kim T, Lee J, et al., 2018, High Neutrophil-to-Lymphocyte Ratio Predicts Stroke-Associated Pneumonia. Stroke, 49(8): 1886–1892.

Xue J, Huang W, Chen X, et al., 2017, Neutrophil-to-Lymphocyte Ratio for Predicting Cardiogenic Stroke in Patients with Atrial Fibrillation. Medicine, 96(30): e7637.

Hu B, Yang X, Xu Y, et al., 2014, Systemic Immune-Inflammation Index Predicts Prognosis of Patients After Curative Resection for Hepatocellular Carcinoma. Clinical Cancer Research, 20(23): 6212–6222.

Geng Y, Shao Y, Zhu D, et al., 2016, Systemic Immune-Inflammation Index Predicts Prognosis of Patients with Esophageal Squamous Cell Carcinoma: A Propensity Score-Matched Analysis. Scientific Reports, 2016(6): 39482.

Chen J, Zhai E, Yuan Y, et al., 2017, Systemic Immune-Inflammation Index for Predicting Prognosis of Colorectal Cancer. World Journal of Gastroenterology, 23(34): 6261–6272.

Iadecola C, Anrather J, 2011, The Immunology of Stroke: From Mechanisms to Translation. Nature Medicine, 17(7): 796–808.

Chamorro Á, Meisel A, Planas A, et al., 2012, The Immunology of Acute Stroke. Nature Reviews Neurology, 8(7): 401–410.

Jin R, Yang G, Li G, 2010, Inflammatory Mechanisms in Ischemic Stroke: Role of Inflammatory Cells. Journal of Leukocyte Biology, 87(5): 779–789.

Jickling G, Liu D, Ander B, et al., 2015, Targeting Neutrophils in Ischemic Stroke: Translational Insights from Experimental Studies. Journal of Cerebral Blood Flow & Metabolism, 35(6): 888–901.

Liesz A, Suri-Payer E, Veltkamp C, et al., 2009, Regulatory T Cells are Key Cerebroprotective Immunomodulators in Acute Experimental Stroke. Nature Medicine, 15(2): 192–199.

Swirski F, Nahrendorf M, 2013, Leukocyte Behavior in Atherosclerosis, Myocardial Infarction, and Heart Failure. Science, 339(6116): 161–166.

Fest J, Ruiter R, Ikram M, et al., 2018, Reference Values for White Blood-Cell-Based Inflammatory Markers in the Rotterdam Study: A Population-Based Prospective Cohort Study. Scientific Reports, 8(1): 10566.

Straub R, 2007, The Complex Role of Estrogens in Inflammation. Endocrine Reviews, 28(5): 521–574.

Miller V, Duckles S, 2008, Vascular Actions of Estrogens: Functional Implications. Pharmacological Reviews, 60(2): 210–241.

Franceschi C, Campisi J, 2014, Chronic Inflammation (inflammaging) and its Potential Contribution to Age-Associated Diseases. The Journals of Gerontology: Series A, 69(Suppl. 1): S4–S9.

Donath M, Shoelson S, 2011, Type 2 Diabetes as an Inflammatory Disease. Nature Reviews Immunology, 11(2): 98–107.

Harrison D, Guzik T, Lob H, et al., 2011, Inflammation, Immunity, and Hypertension. Hypertension, 57(2): 132–140.

Whiteley W, Tseng M, Sandercock P, 2008, Blood Biomarkers in the Diagnosis of Ischemic Stroke: A Systematic Review. Stroke, 39(10): 2902–2909.

Bustamante A, Simats A, Vilar-Bergua A, et al., 2016, Blood/Brain Biomarkers of Inflammation After Stroke and their Association with Outcome: From C-Reactive Protein to Damage-Associated Molecular Patterns. Neurotherapeutics, 13(4): 671–684.

Katan M, Moon Y, Paik M, et al., 2013, Infectious Burden and Cognitive Function: The Northern Manhattan Study. Neurology, 80(13): 1209–1215.

Tokgoz S, Kayrak M, Akpinar Z, et al., 2013, Neutrophil Lymphocyte Ratio as a Predictor of Stroke. Journal of Stroke and Cerebrovascular Diseases, 22(7): 1169–1174.